Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.30 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18308737 | 0.94 | ESR2 (0.35) | ESR2ESR1 | |
| SCHEMBL18806014 | 0.88 | ESR1 (0.32) | ESR2ESR1 | |
| SCHEMBL18308804 | 0.86 | HTR7 (0.36) | ESR2HTR7ESR1AKR1C3AKR1C2 | |
| SCHEMBL18308765 | 0.86 | ESR1 (0.34) | ESR2ESR1 | |
| SCHEMBL18308810 | 0.85 | HTR7 (0.35) | ESR2HTR7ESR1AKR1C3AKR1C2 | |
| SCHEMBL18806009 | 0.84 | ESR2 (0.33) | ESR2ESR1 | |
| SCHEMBL18308785 | 0.83 | HTR7 (0.37) | ESR2HTR7ESR1PTPN1AKR1C3 | |
| SCHEMBL18806015 | 0.82 | HTR7 (0.38) | ESR2HTR7AKR1C3AKR1C2 | |
| SCHEMBL18308803 | 0.81 | MAPT (0.40) | ESR2ESR1AKR1C3AKR1C2 | |
| SCHEMBL18621858 | 0.80 | MEN1 (0.40) | ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| US-20170121606-A1 | POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | GMBH, MERCK PATENT (DE) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | VCL, ILK, LCP1 | ESR2 4146/4885HTR7 4174/4885ESR1 2744/4885 |
| US-20170121606-A1 | POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | VCL, LCP1, MAP1LC3C | ESR2 4322/4885HTR7 3960/4885ESR1 2626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.